Work

Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial

Year: 2012

Type: article

Study design: Clinical Trial

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2012.08.017

Authors: Madeleine Duvic, Reinhard Dummer, Jürgen C. Becker, Nicolas Poulalhon, Pablo Ortiz Romero, Maria Grazia Bernengo, Celeste Lebbé, Chalid Assaf, Margaret Squier, Denise Williams, Miriam Marshood, Feng Tai, H. Miles Prince

Institutions: The University of Texas MD Anderson Cancer Center, University Hospital Zurich, Medical University of Graz, Hôpital Lyon Sud, Universidad Complutense de Madrid, Research Institute Hospital 12 de Octubre, University of Turin, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, Université Paris Diderot, Helios Klinikum Krefeld, Charité – Universitätsmedizin Berlin, The University of Melbourne, Peter MacCallum Cancer Centre

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Novartis Pharmaceuticals Corporation

OpenAlex ID: W2061152470

FWCI: 16.03

Cites: 32

Cited by: 127

Related to: 10